Other Information
+Added: Exhibit Number
+Added: Description of Exhibit
+Added: Third Amended and Restated Bylaws of the Company.
+Added: Incorporated by reference to Exhibit 3.3 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
+Added: OptimizeRx Corporation Executive Severance Plan.
+Added: Incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
+Added: Fourth Addendum to the Employment Agreement with William J.
+Added: Incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
Certification of Chief Executive Officer pursuant to 18 U.S.C.
6 unchanged sentences
Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Calculation
−Removed: Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase
−Removed: Inline XBRL Taxonomy Extension Label Linkbase
−Removed: Cover Page Interactive
−Removed: Data File (formatted as Inline XBRL and contained in Exhibit 101)
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: Inline XBRL Taxonomy Extension Definition Linkbase Document
+Added: Inline XBRL Taxonomy Extension Label Linkbase Document
+Added: Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
** Provided herewith.
2 unchanged sentences
OptimizeRx Corporation
−Removed: November 8, 2022
/s/ William J.
2 unchanged sentences
OptimizeRx Corporation
−Removed: November 8 2022
/s/ Edward Stelmakh
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.